Skip to main content
Livermore
Livermore
ZHEN

Amicus Therapeutics, Inc.

FOLDDelisted Apr 27, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001178879

Amicus Therapeutics, Inc. was delisted on Apr 27, 2026; its insiders filed their last Form 4 on Apr 27, 2026; 298 institutions reported holding it in 13F filings for Q1 2026, worth $4.81B in total; Soros Fund Management was the only superinvestor holding it.

Q3 2023 vs. Q2 2023

How the institutions holding Amicus Therapeutics, Inc. changed between Q2 2023 and Q3 2023.

All holders in Q3 2023All holders in Q2 2023

13F holders of FOLD: Q2 2023 compared with Q3 2023
MeasureQ2 2023Of which not filed for Q3 2023Q3 2023Change
Holders2161229+14
Shares307.3M9.44M298.7M+834.6K (+0.3%)
Value$3.86B$118.6M$3.63B−$105.1M (−2.8%)

1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (33)

Institutions that held Amicus Therapeutics, Inc. at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to FOLD in Q3 2023
InstitutionSharesValue% of portfolio
Pictet Asset Management Holding SA8,397,511$102.1M0.13%
Walleye Capital LLC172,169$2.09M0.03%
Renaissance Technologies LLC148,400$1.80M0.00%
SG Americas Securities, LLC125,014$1.52M0.02%
International Biotechnology Trust PLC90,000$1.09M0.37%
Twinbeech Capital LP87,795$1.07M0.02%
Cookson Peirce & Co Inc63,058$767.0K0.05%
Marshall Wace, LLP62,114$755.3K0.00%
Trexquant Investment LP59,976$729.3K0.02%
Walleye Trading LLC46,474$565.1K0.01%
Graham Capital Management, L.P.45,685$555.5K0.02%
Aquatic Capital Management LLC42,400$516.0K0.02%
Blair William & Co35,454$431.1K0.00%
Aigen Investment Management, LP31,695$385.4K0.07%
Simplex Trading, LLC31,319$380.0K0.01%
Nebula Research & Development LLC20,280$246.6K0.13%
Empire Financial Management Company, LLC20,000$243.2K0.11%
MQS Management LLC19,905$242.0K0.15%
Duality Advisers, LP17,144$208.5K0.03%
Vident Advisory, LLC16,094$195.7K0.01%
Farallon Capital Management, L.L.C.16,000$194.6K0.00%
Group One Trading, L.P.13,229$160.9K0.01%
Los Angeles Capital Management LLC12,976$157.8K0.00%
Mount Yale Investment Advisors, LLC11,083$134.8K0.01%
Campbell & CO Investment Adviser LLC11,012$133.9K0.02%
Legato Capital Management LLC10,550$128.3K0.02%
Park Avenue Securities LLC10,524$128.0K0.00%
KBC Group NV5,024$61.0K0.00%
Pathway Financial Advisers, LLC1,575$19.2K0.01%
Close Asset Management Ltd600$7.00K0.00%
FinTrust Capital Advisors, LLC147$1.79K0.00%
Larson Financial Group LLC81$9850.00%
Farther Finance Advisors, LLC30$3650.00%

Sold out (19)

Institutions that held Amicus Therapeutics, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.

Institutions that sold out of FOLD in Q3 2023
InstitutionShares, Q2 2023Value, Q2 2023
OrbiMed Advisors LLC1,856,400$23.3M
Integral Health Asset Management, LLC387,000$4.86M
Bank of Montreal290,517$3.80M
Two Sigma Advisers, LP235,676$2.96M
Millennium Management LLC74,680$938.0K
HighVista Strategies LLC62,581$786.0K
Ergoteles LLC60,549$760.5K
Readystate Asset Management LP26,840$337.1K
CIBC Private Wealth Group, LLC24,431$306.9K
XTX Topco Ltd21,416$269.0K
NinePointTwo Capital19,996$251.0K
Alberta Investment Management Corp13,544$170.1K
State of Wyoming13,049$163.9K
Calton & Associates, Inc.10,923$137.2K
Guerra Pan Advisors, LLC10,665$134.0K
Harbor Investment Advisory, LLC5,324$66.9K
Pinebridge Investments, L.P.3,091$38.8K
Quadrant Capital Group LLC725$9.11K
Valley National Advisers Inc20–

Not filed for Q3 2023 yet (1)

Institutions that held Amicus Therapeutics, Inc. at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding FOLD in Q2 2023 that haven't filed for Q3 2023
InstitutionShares, Q2 2023Value, Q2 2023
Pictet Asset Management SA9,442,588$118.6M